Israel Englander Neoleukin Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.68 - $0.91 $113,897 - $152,422	-167,497 Reduced 21.55%	609,651 $506,000
Q1 2023 May 15, 2023	SELL	$0.5 - $0.72 $405,059 - $583,285	-810,119 Reduced 51.04%	777,148 $544,000
Q4 2022 Feb 14, 2023	SELL	$0.4 - $0.55 $43,246 - $59,463	-108,116 Reduced 6.38%	1,587,267 $808,000
Q3 2022 Nov 14, 2022	SELL	$0.69 - $1.33 $290,324 - $559,610	-420,760 Reduced 19.88%	1,695,383 $1.09 Million
Q2 2022 Aug 15, 2022	BUY	$0.92 - $2.25 $810,001 - $1.98 Million	880,436 Added 71.25%	2,116,143 $2.18 Million
Q1 2022 May 16, 2022	BUY	$1.72 - $5.23 $699,088 - $2.13 Million	406,447 Added 49.01%	1,235,707 $2.32 Million
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.75 $2.55 Million - $4.25 Million	548,743 Added 195.62%	829,260 $4 Million
Q3 2021 Nov 15, 2021	BUY	$6.05 - $9.66 $741,403 - $1.18 Million	122,546 Added 77.57%	280,517 $2.03 Million
Q2 2021 Aug 16, 2021	BUY	$9.23 - $13.12 $107,271 - $152,480	11,622 Added 7.94%	157,971 $1.46 Million
Q1 2021 May 17, 2021	BUY	$11.26 - $15.78 $38,858 - $54,456	3,451 Added 2.42%	146,349 $1.8 Million
Q4 2020 Feb 16, 2021	BUY	$10.17 - $14.56 $776,306 - $1.11 Million	76,333 Added 114.67%	142,898 $2.02 Million
Q3 2020 Nov 16, 2020	SELL	$9.68 - $17.01 $1.31 Million - $2.3 Million	-135,106 Reduced 66.99%	66,565 $799,000
Q2 2020 Aug 14, 2020	SELL	$9.95 - $17.05 $5.49 Million - $9.4 Million	-551,270 Reduced 73.22%	201,671 $3.35 Million
Q1 2020 May 14, 2020	BUY	$6.12 - $13.64 $4.32 Million - $9.62 Million	705,297 Added 1480.35%	752,941 $8.57 Million
Q4 2019 Feb 14, 2020	SELL	$2.65 - $12.72 $958,131 - $4.6 Million	-361,559 Reduced 88.36%	47,644 $587,000
Q3 2019 Nov 14, 2019	BUY	$2.33 - $3.76 $953,442 - $1.54 Million	409,203 New	409,203 $1.17 Million

Others Institutions Holding NLTX

# of Institutions

Shares Held

199K

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

199K
Shares

$0
0.18% of portfolio

View Full List

About Neoleukin Therapeutics, Inc.

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

More about NLTX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account